November 1, 2011
Conatus Pharmaceuticals Appoints Dr. Gary Burgess as Senior Vice President and Chief Medical Officer
October 25, 2011
Conatus Pharmaceuticals Terminates Phase 2 Clinical Trial of CTS-1027
April 12, 2011
Conatus Pharmaceuticals Completes the Second Closing of its Series B Private Placement Financing
March 31, 2011
Conatus Pharmaceuticals Presents Results From A Phase 2 Clinical Trial of CTS-1027 in HCV Genotype 1 Null-Responders
March 11, 2011
Conatus Pharmaceuticals will display HCV clinical trial data at the International Liver Congress™ (EASL) in March
February 17, 2011
Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)
February 11, 2011
Conatus pharmaceuticals completes $20 million Series B private placement financing
July 30, 2010
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary